Platinum(II) Complexes with Dipyridophenazine Ligands as Human Telomerase Inhibitors and Luminescent Probes for G-Quadruplex DNA
Authors:
- 8 November 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 131 (5) , 1835-1846
Abstract
A series of platinum(II) complexes containing dipyridophenazine (dppz) and C-deprotonated 2-phenylpyridine (N∧CH) ligands were prepared and assayed for G-quadruplex DNA binding activities. [PtII(dppz-COOH)(N∧C)]CF3SO3 (1; dppz-COOH = 11-carboxydipyrido[3,2-a:2′,3′-c]phenazine) binds G-quadruplex DNA through an external end-stacking mode with a binding affinity of ∼107 dm3 mol−1. G-quadruplex DNA binding is accompanied by up to a 293-fold increase in the intensity of photoluminescence at λmax = 512 nm. Using a biotinylated-primer extension telomerase assay, 1 was shown to be an effective inhibitor of human telomerase in vitro, with a telIC50 value of 760 nM.Keywords
This publication has 96 references indexed in Scilit:
- Quadruplex-Forming Oligonucleotides as Tools in Anticancer Therapy and Aptamers Design: Energetic AspectsCurrent Medicinal Chemistry - Anti-Cancer Agents, 2005
- Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics – current status and future prospectsEuropean Journal of Cancer, 2005
- DNA Helicases as Targets for Anti-Cancer DrugsCurrent Medicinal Chemistry - Anti-Cancer Agents, 2005
- G-Quadruplex Interacting Agents Targeting the Telomeric G-Overhang Are More than Simple Telomerase InhibitorsCurrent Medicinal Chemistry - Anti-Cancer Agents, 2004
- The evolving role of telomerase inhibitors in the treatment of cancerCurrent Medical Research and Opinion, 2003
- Telomere maintenance as a target for anticancer drug discoveryNature Reviews Drug Discovery, 2002
- Telomerase inhibitors: targeting the vulnerable end of cancer?Anti-Cancer Drugs, 2000
- G-quadruplex DNA: a potential target for anti-cancer drug designTrends in Pharmacological Sciences, 2000
- G-Quadruplex DNA as a Target for Drug DesignCurrent Pharmaceutical Design, 2000
- G-quadruplex DNA: A target for drug designNature Medicine, 1998